Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvation Bio, Inc.

3.49
-0.4100-10.51%
Post-market: 3.530.0400+1.15%19:56 EDT
Volume:14.58M
Turnover:50.21M
Market Cap:1.19B
PE:-5.55
High:3.83
Open:3.82
Low:3.20
Close:3.90
52wk High:4.09
52wk Low:1.54
Shares:342.27M
Float Shares:231.05M
Volume Ratio:1.59
T/O Rate:6.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6288
EPS(LYR):-2.1131
ROE:-44.84%
ROA:20.17%
PB:3.20
PE(LYR):-1.65

Loading ...

Nuvation Bio Price Target Maintained With a $6.00/Share by Wedbush

Dow Jones
·
Yesterday

Nuvation Bio Says Potential Non-Small Cell Lung Cancer Drug Shows 'Impressive' Progression-Free Survival

MT Newswires Live
·
Yesterday

Nuvation Bio announces new data from Phase 2 studies of IBTROZI

TIPRANKS
·
Sep 07

Nuvation Bio Announces Promising Results from Phase 2 Studies of IBTROZI™ in ROS1-Positive Lung Cancer at 2025 Conference

Reuters
·
Sep 07

Nuvation Bio Announces New Data From Pivotal Clinical Studies of Ibtrozi™ (Taletrectinib) in Advanced Ros1-Positive Non-Small Cell Lung Cancer at 2025 World Conference on Lung Cancer

THOMSON REUTERS
·
Sep 07

Nuvation Bio Up Over 5%, On Track for Highest Close Since August 2024 -- Data Talk

Dow Jones
·
Sep 05

Nuvation Bio Inc. to Attend Cantor Global Healthcare Conference 2025 in New York

Reuters
·
Aug 28

Nuvation Bio Is Maintained at Outperform by RBC Capital

Dow Jones
·
Aug 09

Stock Track | Nuvation Bio (NUVB) Soars 5.13% on Positive Analyst Ratings and Price Target Hikes

Stock Track
·
Aug 08

RBC Raises Price Target on Nuvation Bio to $7 From $6, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Aug 08

Nuvation Bio Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 08

Wedbush Adjusts Nuvation Bio Price Target to $6 From $5, Maintains Outperform Rating

MT Newswires Live
·
Aug 08

Stock Track | Nuvation Bio Soars 5% on Strong Q2 Results and Promising Oncology Breakthroughs

Stock Track
·
Aug 07

Stock Track | Nuvation Bio Plummets 5.32% in Pre-Market Despite Meeting Q2 EPS Estimates, as High Expenses Worry Investors

Stock Track
·
Aug 07

Stock Track | Nuvation Bio Plummets 5.32% Despite Q2 Revenue Beat as Losses Persist

Stock Track
·
Aug 07

Nuvation Bio Inc. Unveils Corporate Presentation Highlighting Breakthroughs in Oncology Treatments

Reuters
·
Aug 07

Earnings Flash (NUVB) Nuvation Bio Posts Q2 Net Loss $0.17 a Share, vs. FactSet Est of $0.16 Loss

MT Newswires Live
·
Aug 07

Nuvation Bio Q2 2025 GAAP EPS $(0.17), Inline, Sales $4.833M Up From $1.435M YoY

Benzinga
·
Aug 07

BRIEF-Nuvation Bio Q2 EPS USD -0.17

Reuters
·
Aug 07

Nuvation Bio Q2 Income From Pperations USD -63.589 Million

THOMSON REUTERS
·
Aug 07